Harbor Health Care ETF (MEDI) Holdings
MEDI holdings summary
as of Oct 24, 2026- Holdings
- 44 positions listed
- Top 10 weight
- 61.2% of net assets
- Effective holdings
- 11 equal-weight equivalent
- Largest holding
- LLY 20.53% Eli Lilly and Company
- Annual turnover
- 129.8% of the portfolio traded
All MEDI holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 20.53% | $8.9M | $1.12T | 42.2 |
| 2 | ASND | Ascendis Pharma A/S | Healthcare | 16.86% | $7.3M | $14.82B | 17.3 |
| 3 | ARGX | argenx SE | Healthcare | 4.90% | $2.1M | $51.51B | 31.2 |
| 4 | PCVX | Vaxcyte, Inc. | Healthcare | 3.36% | $1.5M | $10.01B | — |
| 5 | ISRG | Intuitive Surgical, Inc. | Healthcare | 2.82% | $1.2M | $150.74B | 48.9 |
| 6 | GH | Guardant Health, Inc. | Healthcare | 2.78% | $1.2M | $21.28B | — |
| 7 | INSM | Insmed Incorporated | Healthcare | 2.72% | $1.2M | $21.02B | — |
| 8 | RYTM | Rhythm Pharmaceuticals, Inc. | Healthcare | 2.60% | $1.1M | $5.91B | — |
| 9 | UTHR | United Therapeutics Corporation | Healthcare | 2.40% | $1.0M | $22.87B | 19.1 |
| 10 | RVMD | Revolution Medicines, Inc. | Healthcare | 2.27% | $978,158.91 | $38.14B | — |
| 11 | NTRA | Natera, Inc. | Healthcare | 2.21% | $953,990.86 | $56.71B | — |
| 12 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 1.91% | $824,432.81 | $44.20B | 39.8 |
| 13 | COR | Cencora | Healthcare | 1.73% | $746,965.56 | $65.06B | 25.3 |
| 14 | ABBV | AbbVie Inc. | Healthcare | 1.73% | $746,188.73 | $504.37B | 80.6 |
| 15 | AAVXF | ABIVAX Société Anonyme | Healthcare | 1.65% | $712,051.35 | — | — |
| 16 | HQY | HealthEquity, Inc. | Healthcare | 1.62% | $698,456.82 | $7.61B | 33.2 |
| 17 | HCA | HCA Healthcare, Inc. | Healthcare | 1.52% | $653,875.39 | $99.34B | 15.4 |
| 18 | INDV | Indivior PLC | Healthcare | 1.44% | $621,291.67 | $3.83B | 11.6 |
| 19 | PTCT | PTC Therapeutics, Inc. | Healthcare | 1.44% | $621,205.36 | $4.94B | — |
| 20 | MCK | McKesson Corporation | Healthcare | 1.44% | $620,169.58 | $117.15B | 26.9 |
| 21 | DHR | Danaher Corporation | Healthcare | 1.39% | $598,720.43 | $161.01B | 40.8 |
| 22 | XENE | Xenon Pharmaceuticals Inc. | Healthcare | 1.19% | $514,175.39 | $3.24B | — |
| 23 | GKOS | Glaukos Corporation | Healthcare | 1.18% | $507,831.28 | $9.72B | — |
| 24 | LEGN | Legend Biotech Corporation | Healthcare | 1.13% | $486,036.87 | $3.59B | — |
| 25 | UNH | UnitedHealth Group Incorporated | Healthcare | 1.04% | $449,569.00 | $360.32B | 25.8 |
| 26 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.04% | $449,094.27 | $126.66B | 28.9 |
| 27 | IRTC | iRhythm Technologies, Inc. | Healthcare | 1.04% | $448,964.80 | $3.58B | — |
| 28 | MRK | Merck & Co., Inc. | Healthcare | 1.00% | $433,082.93 | $360.08B | 115.8 |
| 29 | IONS | Ionis Pharmaceuticals, Inc. | Healthcare | 0.99% | $426,479.88 | $7.14B | — |
| 30 | RDNT | RadNet, Inc. | Healthcare | 0.87% | $377,539.56 | $5.41B | — |
| 31 | VTRS | Viatris Inc. | Healthcare | 0.82% | $354,579.91 | $21.43B | — |
| 32 | MDGL | Madrigal Pharmaceuticals, Inc. | Healthcare | 0.82% | $354,191.49 | $10.39B | — |
| 33 | PRAX | Praxis Precision Medicines, Inc. | Healthcare | 0.73% | $313,753.16 | $6.75B | — |
| 34 | AXSM | Axsome Therapeutics, Inc. | Healthcare | 0.71% | $305,208.02 | $8.23B | — |
| 35 | SYRE | Spyre Therapeutics, Inc. | Healthcare | 0.68% | $292,908.21 | $7.47B | — |
| 36 | ORKA | Oruka Therapeutics, Inc. | Healthcare | 0.60% | $260,799.22 | $4.76B | — |
| 37 | RLAY | Relay Therapeutics, Inc. | Healthcare | 0.60% | $260,367.65 | $3.57B | — |
| 38 | TXG | 10x Genomics, Inc. | Healthcare | 0.51% | $220,145.10 | $9.10B | — |
| 39 | KRYS | Krystal Biotech, Inc. | Healthcare | 0.49% | $210,521.03 | $9.37B | 39.7 |
| 40 | ADPT | Adaptive Biotechnologies Corporation | Healthcare | 0.45% | $192,999.19 | $3.83B | — |
| 41 | ELVN | Enliven Therapeutics, Inc. | Healthcare | 0.44% | $189,891.87 | $2.73B | — |
| 42 | SOPH | SOPHiA GENETICS SA | Healthcare | 0.43% | $185,791.93 | $572.9M | — |
| 43 | PVLA | Palvella Therapeutics, Inc | Healthcare | 0.43% | $183,634.07 | $1.73B | — |
| 44 | IVA | Inventiva S.A. | Healthcare | 0.30% | $129,601.20 | $694.5M | — |
Weights as a percentage of net assets. Value held = weight × net assets ($43.2M). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
MEDI sector breakdown
Sum of the weights of the holdings in each sector.
MEDI top industries
MEDI overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| SPY | SPDR S&P 500 ETF | 4.3% | 12 of 502 | 0.09% |
| VTI | Vanguard Total Stock Market ETF | 4.3% | 37 of 2,941 | 0.03% |
| IWM | iShares Russell 2000 ETF | 3.3% | 18 of 1,962 | 0.19% |
| DIA | SPDR Dow Jones Industrial Average ETF | 2.0% | 2 of 30 | 0.16% |
| QQQ | Invesco QQQ ETF | 1.4% | 3 of 101 | 0.17% |
| VXUS | Vanguard Total International Stock ETF | 0.1% | 3 of 8,035 | 0.05% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the MEDI portfolio
Harbor Health Care ETF holds 44 positions. The ten largest make up 61.2% of the fund, so it behaves like a portfolio of about 11 equally weighted stocks. The biggest positions are Eli Lilly and Company (20.53%), Ascendis Pharma A/S (16.86%), argenx SE (4.90%), Vaxcyte, Inc. (3.36%), Intuitive Surgical, Inc. (2.82%).
By sector, Healthcare is 96.8%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 24, 2026; positions change as the fund rebalances.
Related: MEDI chart, MEDI performance, MEDI dividends, MEDI valuation, MEDI overview.
MEDI holdings FAQ
How many holdings does MEDI have?
MEDI holds 44 positions as of October 24, 2026.
What are the top 10 holdings of MEDI?
The ten largest holdings are Eli Lilly and Company (20.53%), Ascendis Pharma A/S (16.86%), argenx SE (4.90%), Vaxcyte, Inc. (3.36%), Intuitive Surgical, Inc. (2.82%), Guardant Health, Inc. (2.78%), Insmed Incorporated (2.72%), Rhythm Pharmaceuticals, Inc. (2.60%), United Therapeutics Corporation (2.40%), Revolution Medicines, Inc. (2.27%). Together they are 61.2% of the fund.
What percentage of MEDI is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 20.53% of net assets, about $8.9M of the fund's $43.2M.
How concentrated is MEDI?
The top 10 holdings are 61.2% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) MEDI behaves like a portfolio of about 11 equally weighted stocks.